Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Everolimus impurity 13 is a notable impurity of the immunosuppressant drug Everolimus. It is utilized primarily for analytical purposes in pharmaceutical research to assess the purity and quality of Everolimus formulations. This compound aids in the development of rigorous quality control methods and contributes to the comprehensive understanding of drug stability and degradation pathways in pharmaceutical sciences. -
Drug Impurity
Ibuprofen impurity 5, also known as Ibuprofen impurity I, is a chemical impurity associated with Ibuprofen. This compound can be utilized in drug formulation studies and analytical chemistry to assess the purity and stability of Ibuprofen formulations. Understanding and monitoring impurities is critical for ensuring the safety and efficacy of pharmaceutical products in research and development settings. -
Drug Impurity
Rufinamide impurity 8 is a known impurity of the anticonvulsant agent Rufinamide. This compound is primarily utilized in the analysis of drug purity and quality control in pharmaceutical research. It serves as an important tool for understanding the stability and degradation pathways of Rufinamide, ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Rosuvastatin impurity 42 is a known impurity associated with the cholesterol-lowering agent Rosuvastatin, primarily targeting HMG-CoA reductase. This compound is critical for quality control in pharmaceutical development and analytical studies to ensure the purity and safety of Rosuvastatin formulations. Research applications include method validation, stability testing, and impurity profiling in drug development processes. -
Naphazoline Impurity
N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide is an impurity associated with Naphazoline. This compound can serve as a reference standard in analytical chemistry for the quality control of Naphazoline formulations. Its identification and quantification are crucial for ensuring the purity and efficacy of pharmaceutical preparations containing Naphazoline. -
Drug Impurity
Clopidogrel impurity 4, known as R-Clopidogrel carboxylic acid, is a recognized impurity of the antiplatelet agent Clopidogrel. This compound is utilized in analytical chemistry and pharmacological research to evaluate the purity and stability of Clopidogrel formulations. Its characterization is essential for regulatory compliance and ensuring the safety and efficacy of Clopidogrel-based therapies. -
Drug Impurity
Etoricoxib impurity 17 is a known impurity of the nonsteroidal anti-inflammatory drug (NSAID) Etoricoxib, which selectively targets cyclooxygenase enzymes (COX-2). This compound is relevant for research concerning drug purity and quality control, particularly in the pharmaceutical development of Etoricoxib. Analysis of this impurity may help in understanding the metabolic pathways and stability profiles of NSAIDs in clinical formulations. -
Drug Impurity
Meloxicam impurity 1 is identified as a chemical impurity associated with Meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) that primarily targets cyclooxygenase enzymes (COX-1 and COX-2). This impurity is utilized in research applications focused on drug quality assessment and stability testing. Understanding the presence and impact of impurities like Meloxicam impurity 1 is essential for ensuring the safety and efficacy of pharmaceutical formulations. -
Drug Impurity
Buspirone impurity 6 is a known impurity associated with the anxiolytic agent Buspirone. Its characterization is crucial for ensuring the purity and quality of Buspirone formulations. This reagent is primarily used in analytical chemistry for method development, quality control, and regulatory compliance in pharmaceutical research. -
Drug Impurity
Trazodone impurity 12 is a drug impurity associated with Trazodone. It is significant for analytical chemistry applications, particularly in the characterization of pharmaceutical formulations and stability testing. The identification and quantification of this impurity can provide important insights into the purity profiles of Trazodone in various research settings. -
Drug Impurity
Tenofovir impurity 2 fumarate, also known as (S)-Tenofovir disoproxil fumarate, is a prominent impurity associated with Tenofovir fumarate. This compound serves as a critical reference standard in pharmaceutical research, particularly in enforcing quality control during the synthesis of Tenofovir formulations. Its characterization is vital for ensuring the purity and efficacy of drug products in the development of antiretroviral therapies. -
Drug Impurity
Metoprolol impurity 11 is a known impurity associated with the beta-adrenergic blocker metoprolol. Its presence is critical for investigative studies focused on drug quality and stability, as well as for elucidating potential impacts on pharmacokinetics and pharmacodynamics. Researchers can utilize this impurity to assess the purity of metoprolol formulations and ensure compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Duloxetine impurity 9 is identified as a chemical impurity associated with the synthesis of Duloxetine. It serves as a critical reference standard for quality control and validation in pharmaceutical research and analysis. Researchers can utilize this impurity to assess the purity and stability of Duloxetine formulations, contributing to the overall understanding of its pharmacological profile and enhancing compliance with regulatory standards. -
Drug Impurity
Salbutamol impurity 14 is a known impurity associated with Salbutamol, a β2-adrenergic agonist. This compound is important for analytical and quality control purposes in pharmaceutical research, as it aids in the assessment of the purity and stability of Salbutamol formulations. Salbutamol impurity 14 is also relevant for toxicity studies and regulatory compliance in drug development. -
Drug Impurity
Losartan impurity 18, also known as Trithyl Losartan, is a structural impurity associated with the antihypertensive medication Losartan. This compound is primarily utilized in pharmaceutical research to assess the purity and quality of Losartan formulations. It serves as a crucial reference standard for analytical methods aimed at detecting impurities in drug development and quality control processes. -
Drug Impurity
Atorvastatin impurity 6 calcium is a characterized impurity of Atorvastatin calcium, primarily noted for its relevance in quality control assessments. This compound is utilized in analytical chemistry and pharmacokinetic studies to ensure the purity and efficacy of statin-based therapeutic formulations. It serves as a critical reference standard for the identification and quantification of potential contaminants in drug development and regulatory compliance. -
Drug Impurity
Aripiprazole impurity 4 is a chemical impurity associated with the antipsychotic medication Aripiprazole. This compound serves as an important reference standard for quality control and analytical validation processes in pharmaceutical research. It plays a critical role in ensuring the safety and efficacy of Aripiprazole formulations by allowing for the identification and quantification of impurities in drug testing. -
Drug Impurity
Tetrabenazine impurity 1 is a byproduct of Tetrabenazine, serving primarily as a drug impurity in quality control and research. Its presence is important for analytical studies and ensuring the purity of pharmaceutical formulations. Investigating impurities like Tetrabenazine impurity 1 can aid in understanding the stability and safety profiles of related compounds. -
Drug Impurity
Buvacitam impurity 27 is an impurity related to Buvacitam, primarily serving as a reference standard for quality control and analytical assessment in pharmaceutical research. It is used to evaluate the purity of Buvacitam and ensure compliance with regulatory standards. This compound plays a crucial role in the development and validation of analytical methods in drug formulation studies. -
Drug Impurity
Candesartan impurity 31 is a drug impurity associated with the antihypertensive agent Candesartan, acting as an angiotensin II receptor blocker. This compound is crucial for quality control and method validation in pharmaceutical development, enabling accurate assessment of Candesartan's purity profile. It serves as a valuable reference standard for analytical studies to ensure compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Prasugrel impurity 1 is a chemical impurity associated with the antiplatelet drug Prasugrel. This compound is important for analytical and quality control studies, particularly in the pharmaceutical industry, to ensure the purity and safety of Prasugrel formulation. Its characterization can aid in understanding the metabolic pathways and potential side effects of the primary drug. Researchers may use this impurity for method development and validation in the context of drug analysis. -
Drug Impurity
Donepezil impurity 3, also known as Dehydrodeoxy donepezil, is a known impurity associated with the Alzheimer’s disease treatment compound, Donepezil. This impurity is essential for analytical studies and quality control assessments during the synthesis and characterization of Donepezil. It serves as a reference standard in the evaluation of the purity and stability of pharmaceutical formulations, aiding in compliance with regulatory requirements. -
Drug Impurity
Chlorthalidone impurity 5 is a known impurity of the antihypertensive agent chlorthalidone, which primarily acts as a thiazide-like diuretic. Its identification and quantification are essential for ensuring the quality and regulatory compliance of chlorthalidone formulations. This impurity can be utilized in pharmaceutical research to study drug stability, metabolism, and potential effects on drug efficacy and safety profiles. -
Drug Impurity
Rosuvastatin impurity 56 is a chemical impurity associated with Rosuvastatin, a statin drug primarily targeting HMG-CoA reductase. This compound is useful for quality control and characterization in the pharmaceutical industry, facilitating the analysis of drug purity and stability. It plays a significant role in regulatory compliance and ensures the safety and efficacy of drug formulations. -
Drug Impurity
Tacrolimus impurity 2, also known as Tacrolimus hydroxy acid, represents a significant impurity associated with Tacrolimus. This compound is primarily utilized for analytical purposes in drug quality assessments, enabling researchers to evaluate the purity and stability of Tacrolimus formulations. Its presence can influence pharmacological properties and is essential for ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Rufinamide impurity 5 is a byproduct associated with the synthesis of Rufinamide, which is an anticonvulsant medication. This compound is primarily used in analytical chemistry and pharmaceutical research to assess the purity and stability of Rufinamide formulations. Its presence can provide insights into the synthesis process and contribute to improving the quality control measures in drug development. -
Drug Impurity
Roxithromycin impurity 5, also known as N-Demethylroxithromycin, is an impurity associated with the antibiotic Roxithromycin. This compound is primarily used in the pharmaceutical industry to study the quality and stability of Roxithromycin formulations. Its presence serves as a point of reference for the identification and quantification of related impurities, contributing to the assessment of drug purity and efficacy in research applications. -
Drug Impurity
Rivastigmine impurity 3 is a known impurity of the acetylcholinesterase inhibitor, Rivastigmine. This compound is utilized in quality control and analytical chemistry to assess the purity of Rivastigmine formulations. Its presence can significantly impact the safety and efficacy profiles of pharmaceutical products, making it relevant for regulatory compliance and drug development studies. -
Drug Impurity
Cetirizine impurity D hydrochloride is a known impurity associated with Cetirizine D hydrochloride. It is commonly utilized in pharmaceutical research to assess the purity and quality of cetirizine formulations. Analyzing this impurity is essential for ensuring compliance with regulatory standards and for the development of safe and effective drug products. -
Drug Impurity
Abacavir impurity 3 is a drug impurity associated with the antiretroviral agent Abacavir, commonly used in the treatment of HIV. This compound is essential for quality control and method validation in pharmaceutical research. Abacavir impurity 3 serves as a critical reference standard for assessing the purity and stability of abacavir formulations, aiding in the development of safe and effective medications. -
Drug Impurity
Pentoxifylline impurity 1 is a known impurity of Pentoxifylline, a xanthine derivative that primarily targets phosphodiesterase enzymes. This compound is relevant for analytical studies in drug formulation and quality control, providing insight into the purity and stability of Pentoxifylline preparations. It is often utilized in research focusing on drug metabolism, stability testing, and pharmacokinetic profiling. -
Drug Impurity
Cinacalcet impurity 3 is a recognized impurity associated with the drug Cinacalcet, a calcimimetic agent that acts primarily on the calcium-sensing receptor (CaSR). This compound is essential for understanding the purity and stability of Cinacalcet formulations, providing valuable insights in drug development and quality control processes. Its characterization plays a critical role in assessing the safety and efficacy of therapeutic products. -
Drug Impurity
Atenolol impurity 4 is a known impurity associated with Atenolol, a beta-adrenergic antagonist. This compound may be utilized for analytical and quality control purposes in drug development, particularly in the evaluation of Atenolol formulations. Its presence and quantification are essential for ensuring the safety and efficacy of pharmaceutical products containing Atenolol. -
Drug Impurity
Donepezil impurity 6 hydrochloride is a known impurity of the acetylcholinesterase inhibitor Donepezil hydrochloride. This compound is critical in the analysis of drug purity and assists in the characterization of donepezil formulations during research and development. Its presence is essential for quality control and safety assessments in the pharmaceutical industry. -
Drug Impurity
Candesartan impurity 5 is a known impurity associated with the angiotensin II receptor blocker Candesartan. Its characterization is essential for quality control and compliance in pharmaceutical development. This compound is primarily utilized in analytical studies to evaluate the purity of Candesartan formulations and to ensure adherence to regulatory standards in drug manufacturing. -
Drug Impurity
Rosuvastatin impurity 6 is a known impurity associated with the cholesterol-lowering agent Rosuvastatin. It is primarily utilized in analytical research for the characterization and quantification of pharmaceutical formulations. This compound is essential for ensuring the purity and quality of Rosuvastatin in drug development and quality control processes. -
Drug Impurity
Simvastatin impurity 12 is a chemical byproduct associated with Simvastatin. This compound is utilized in pharmaceutical research to evaluate the purity and quality of Simvastatin formulations. Its presence is critical for assessing the stability and safety profiles of lipid-lowering therapies in drug development and regulatory compliance. -
Drug Impurity
Clindamycin palmitate impurity 2, also known as Clindamycin myristate, is a recognized drug impurity associated with the antibiotic clindamycin. This compound is important for research applications focusing on drug formulation and analysis of pharmaceutical products. Its study assists in understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Simvastatin impurity 9 is a known impurity associated with the cholesterol-lowering agent Simvastatin. It serves as a critical reference standard for analytical chemistry, particularly in the assessment of drug purity and stability. This compound is utilized in pharmaceutical research to ensure compliance with regulatory guidelines and to investigate the potential effects of impurities on drug efficacy and safety. -
Drug Impurity
Hydrocortisone impurity 8 is a known impurity related to Hydrocortisone, primarily analyzed for its impact on drug formulation and quality. This compound serves as a critical reference standard for assessing the purity of Hydrocortisone in pharmaceutical studies. Its detection and quantification are essential for ensuring the safety and efficacy of corticosteroid-based therapies in research and development settings. -
Drug Impurity
Itraconazole impurity 1 is a known impurity of the antifungal agent Itraconazole. This compound is essential for investigating potential effects on drug formulation integrity and safety profiles. It serves as a critical component for analytical chemistry applications, particularly in quality control and stability testing of pharmaceutical formulations containing Itraconazole. -
Drug Impurity
Fluphenazine impurity 1 is a chemical impurity derived from Fluphenazine. This compound is relevant in studies concerning drug formulation and stability, as well as in the assessment of pharmaceutical quality and safety. Research involving Fluphenazine impurity 1 can provide insight into metabolite profiling and the identification of potential side effects associated with Fluphenazine. -
Drug Impurity
Dabigatran impurity 43 is a known impurity associated with Dabigatran, an oral direct thrombin inhibitor. This compound is utilized in the pharmaceutical analysis of Dabigatran to assess drug quality and safety in research and development. Its characterization is essential for understanding the pharmacological properties and potential side effects of the primary drug compound. -
Drug Impurity
Afatinib impurity 33 is a chemical byproduct associated with the synthesis of Afatinib, an irreversible inhibitor of the epidermal growth factor receptor (EGFR). This impurity serves as a reference standard for quality control and methods validation in pharmaceutical research. Its presence is important for the characterization and assessment of Afatinib formulations in drug development and manufacturing processes. -
Drug Impurity
Erythromycin impurity 4 is a known impurity derived from Erythromycin, a macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit. This compound is utilized primarily in pharmaceutical research for the characterization and assessment of drug purity in Erythromycin formulations. Its presence may affect the biological efficacy and safety profiles of antibiotic products, making it a crucial component for quality control in drug development. -
Drug Impurity
Aglutin impurity 1 is a characterized impurity associated with the drug Aglutin. It is essential for the assessment of purity and quality in pharmaceutical formulations. This reagent can be used in analytical methods to quantify impurities, ensuring compliance with regulatory standards for drug manufacturing. -
Drug Impurity
Lamivudine Impurity 5 is a defined impurity associated with the antiretroviral drug Lamivudine. This compound is primarily utilized in pharmaceutical research to assess the quality and purity of Lamivudine formulations. It serves as a critical reference standard for analytical methods such as HPLC and is essential for regulatory compliance in the development of HIV therapies. -
Drug Impurity
Thioridazine impurity 1, also known as Thioridazine 5-sulfoxide, is a characterized impurity associated with the antipsychotic agent Thioridazine. This compound is relevant in the context of pharmaceuticals as it may impact the efficacy and safety profile of Thioridazine formulations. Researchers can utilize Thioridazine impurity 1 in the assessment of drug quality, stability studies, and the analysis of therapeutic formulations. -
Drug Impurity
Clindamycin palmitate impurity 10, also known as Clindamycin 4-palmitate, is classified as a drug impurity associated with clindamycin formulations. Its presence can significantly affect the pharmacological profile and stability of drug products. This compound is primarily used in pharmaceutical research to ensure the purity and efficacy of clindamycin formulations, aiding in the analysis and development of safer therapeutic interventions. -
Drug Impurity
Rivaroxaban impurity 26 is a known impurity of the anticoagulant medication Rivaroxaban. This compound serves as a reference standard for the detection and quantification of impurities in pharmaceutical formulations. It is essential for quality control and regulatory compliance in drug development, ensuring the safety and efficacy of Rivaroxaban products.
